Resectable Rectal Cancer: Preoperative Short-Course Radiation
Publisher
Springer Netherlands
Reference43 articles.
1. Basha, G., Landuyt, W., Fowler, J., Vordermark, D., Haustermans, K., Geboes, K., Van den Bogaert, W.,Yap, S. H., Lambin, P., and Penninckx, F. 2002. An experimental evaluation of three preoperative radiation regimens for resectable rectal cancer. Ann. Surg. Oncol. 9: 292–297. 2. Birgisson, H., Pahlman, L., Gunnarsson, U., and Glimelius, B. 2005. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J. Clin. Oncol. 23: 8697–8705. 3. Bosset, J. F., Calais, G., Daban, A., Berger, C., Radosevic-Jelic, L., Maingon, P., Berdet, E., Pierart, M., and Briffaux, A., EORTC Radiotherapy Group. 2004. Preoperative chemo-radiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. 4. Brooks, S., Glynne-Jones, R., Novell, R., Harrison, M., Brown, K., and Makris, A. 2006. Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer. Acta Oncol. 45: 1079–1085. 5. Bujko, K., Nowacki, M.P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M., Pudelko, M., Kryj, M., Oledzki, J., Szmeja, J., Sluszniak, J., Serkies, K., Kladny, J., Pamucka, M., and Kukolowicz P. 2004. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother. Oncol. 72: 15–24.
|
|